FEBNM

Certificate of Fellowship of the European Board of Nuclear Medicine

Prostate Radioligand TherapyEnglish
Exam overview

Practice session

A man undergoing lutetium-177 PSMA therapy reports xerostomia after prior cycles. Which organ uptake best explains this toxicity risk?

Loading your practice session…